On Sept. 10, The Economist announced JBEI’s CEO Jay Keasling as the winner of its 2014 Innovation Award in the Bioscience category. In addition to being JBEI’s CEO, Keasling is a Professor of Chemical Engineering at the University of California, Berkeley and Senior Faculty Scientist and Associate Lab Director at Berkeley Lab. He was recognized for his development of synthetic artemisinin used to treat malaria. The award, which recognizes an outstanding person who has made a proven innovation over the past decade, will be presented to Keasling at a ceremony in Hong Kong on October 9th. Keasling will also speak at The Economist Events’ Innovation Summit taking place in Hong Kong the next day.